09:22:34 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



Neupath Health Inc
Symbol NPTH
Shares Issued 56,212,336
Close 2023-09-05 C$ 0.15
Market Cap C$ 8,431,850
Recent Sedar Documents

Neupath closes London, Ont., medical facility sale

2023-09-05 16:10 ET - News Release

Mr. Jeff Zygouras reports

NEUPATH SUCCESSFULLY COMPLETES SALE OF CORPORATE-OWNED MEDICAL FACILITY

Neupath Health Inc. has provided an update on the sale of its corporate-owned medical facility, which had previously been announced on March 15, 2023.

The company has completed the previously announced sale of its sole corporate-owned medical facility in London, Ont., and has received net funds after fees, taxes and repayment of the mortgage of more than $500,000. The net proceeds from this sale were invested in the construction of, and move to, the company's new location, and for working capital and general corporate purposes.

"I want to thank our London InMedic team for efficiently and successfully migrating our operations to this newer, more modern facility to better serve our patients," said Joe Walewicz, chief executive officer. "We will continue to execute on our facilities optimization strategy to strengthen our balance sheet and improve margins, which will allow us to invest in our clinics and other growth initiatives."

About Neupath Health Inc.

Neupath operates a network of health care clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centred multidisciplinary care. The company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. In addition, Neupath provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers, as well as contract research services to pharmaceutical and biotechnology companies. Neupath is focused on enabling individuals it treats to live their best life.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.